These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14987468)

  • 1. The NMDA NR2B subunit-selective receptor antagonist, CP-101,606, enhances the functional recovery the NMDA NR2B subunit-selective receptor and reduces brain damage after cortical compression-induced brain ischemia.
    Kundrotiene J; Cebers G; Wägner A; Liljequist S
    J Neurotrauma; 2004 Jan; 21(1):83-93. PubMed ID: 14987468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient down-regulation of NMDA receptor subunit gene expression in the rat retina following NMDA-induced neurotoxicity is attenuated in the presence of the non-competitive NMDA receptor antagonist MK-801.
    Goebel DJ; Poosch MS
    Exp Eye Res; 2001 May; 72(5):547-58. PubMed ID: 11311046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extradural compression of sensorimotor cortex: a useful model for studies on ischemic brain damage and neuroprotection.
    Kundrotiené J; Wägner A; Liljequist S
    J Neurotrauma; 2002 Jan; 19(1):69-84. PubMed ID: 11852980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model.
    Nakazato E; Kato A; Watanabe S
    Pharmacology; 2005 Jan; 73(1):8-14. PubMed ID: 15452358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
    Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
    J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease.
    Nash JE; Ravenscroft P; McGuire S; Crossman AR; Menniti FS; Brotchie JM
    Exp Neurol; 2004 Aug; 188(2):471-9. PubMed ID: 15246846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoro-Jade and TUNEL staining as useful tools to identify ischemic brain damage following moderate extradural compression of sensorimotor cortex.
    Kundrotiene J; Wägner A; Liljequist S
    Acta Neurobiol Exp (Wars); 2004; 64(2):153-62. PubMed ID: 15366248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient global ischemia in rat brain promotes different NMDA receptor regulation depending on the brain structure studied.
    Dos-Anjos S; Martínez-Villayandre B; Montori S; Regueiro-Purriños MM; Gonzalo-Orden JM; Fernández-López A
    Neurochem Int; 2009; 54(3-4):180-5. PubMed ID: 19103243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ketamine-midazolam anesthesia on the expression of NMDA and AMPA receptor subunit in the peri-infarction of rat brain.
    Zhang YL; Zhang PB; Qiu SD; Liu Y; Tian YF; Wang Y
    Chin Med J (Engl); 2006 Sep; 119(18):1555-62. PubMed ID: 16996010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuroprotective effects of NMDAR antagonist, ifenprodil and ASIC1a inhibitor, flurbiprofen on post-ischemic cerebral injury.
    Mishra V; Verma R; Singh N; Raghubir R
    Brain Res; 2011 May; 1389():152-60. PubMed ID: 21396924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs.
    Barton ME; White HS; Wilcox KS
    Epilepsy Res; 2004 Mar; 59(1):13-24. PubMed ID: 15135163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different action of a specific NR2B/NMDA antagonist Ro 25-6981 on cortical evoked potentials and epileptic afterdischarges in immature rats.
    Szczurowska E; Mareš P
    Brain Res Bull; 2015 Feb; 111():1-8. PubMed ID: 25446739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent effect of S(+) ketamine on post-ischemic endogenous neurogenesis in rats.
    Winkelheide U; Lasarzik I; Kaeppel B; Winkler J; Werner C; Kochs E; Engelhard K
    Acta Anaesthesiol Scand; 2009 Apr; 53(4):528-33. PubMed ID: 19317867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
    Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
    J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain.
    Ali C; Nicole O; Docagne F; Lesne S; MacKenzie ET; Nouvelot A; Buisson A; Vivien D
    J Cereb Blood Flow Metab; 2000 Jun; 20(6):956-66. PubMed ID: 10894179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist.
    Taniguchi K; Shinjo K; Mizutani M; Shimada K; Ishikawa T; Menniti FS; Nagahisa A
    Br J Pharmacol; 1997 Nov; 122(5):809-12. PubMed ID: 9384494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats.
    Wessell RH; Ahmed SM; Menniti FS; Dunbar GL; Chase TN; Oh JD
    Neuropharmacology; 2004 Aug; 47(2):184-94. PubMed ID: 15223297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors.
    Giovannelli L; Cozzi A; Guarnieri I; Dolara P; Moroni F
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):697-704. PubMed ID: 12045668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.